Insider buying last 90 days
No open-market insider purchases were filed for AHR in the last 90 days.
From Form 4 filings, dated to when each was filed.
Nov 13 close
American Healthcare REIT touched an all-time high of $58.69 this week after third-quarter results showed revenue rising to $742.1 million from $572.9 million a year earlier, alongside an eleventh consecutive quarter of double-digit same-store NOI growth at 13.8%. Management raised full-year guidance, now forecasting 2026 normalized funds from operations of $2.23 to $2.26 per share and lifting the same-store NOI growth target to 12%-14%, while year-to-date investments reached $2.1 billion. The company also launched a $1.75 billion at-the-market equity program as shares traded near their 52-week high, having risen nearly 21% year-to-date.
The stock closed at $58.96, up 1.8% on the day, and sits above both its 50-day average of $53.16 and 200-day average of $51.73, with the 50-day above the 200-day. The GekkoIndex reads 40.3, placing AHR in the Distribution zone. Price stands 12% above Gekko Fair Value of $52.63.
The next earnings date falls on 25 February 2027, 107 days out and beyond a typical 20-trading-day holding window. All 11 covering analysts currently carry buy ratings, with a consensus target of $63.69 implying 8% upside. No insider, Congress or unusual options activity appears in the recent windows, and there is not enough seasonal history for a read, leaving trend strength and the fair-value gap as the main reference points for the period ahead.
Written by AI from the Nov 9, 2026 close and checked automatically against the figures on this page.
American Healthcare REIT scores 2 supportive, 1 mixed and 1 headwind across the 4 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
2 supportive1 mixed1 headwind
Above 50 and 200-day
Close $57.78 is above the 50-day ($53.39) and 200-day ($51.98) averages, and the 50-day is above the 200-day.
See the chart46.6, Neutral
Reading 46.6 is in the Neutral zone.
See the GekkoIndex10.4% above
Price is 10.4% above Gekko Fair Value (more than 5% above).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 102 days
Next report Feb 25, 2027, 102 days away — outside a typical 20-trading-day hold.
See earningsNo data
Not enough years of history for a seasonal read.
A description of current data, not a recommendation. How this page works
American Healthcare REIT closed at $57.78 on Nov 13, 2026, +20.7% over the past year, inside a 52-week range of $44.81 to $59.55.
Use the left and right arrow keys to read daily values.
Put AHR on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
American Healthcare REIT holds and runs a broad set of healthcare-focused real estate, ranging from medical office buildings to senior housing communities, skilled nursing facilities, and combined senior health campuses. Its properties are spread across 36 U.S. states as well as the United Kingdom, adding up to 312 sites and roughly 19 million square feet of space, with a total gross investment value near 4.2 billion dollars. The firm is recognized for the breadth of this property base, which traces back to acquisitions made starting in 2014.
The company came together through the combination of Griffin-American Healthcare REIT III, Griffin-American Healthcare REIT IV, and the operating business of American Healthcare Investors. Day-to-day oversight runs through a single management platform staffed by more than a hundred people, a group that includes many who have worked alongside one another since 2006 through multiple real estate cycles. American Healthcare REIT, Inc. functions as a subsidiary of Griffin Capital Company, LLC.
Its shares trade under the ticker AHR.
American Healthcare REIT’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 46.6, in the Neutral zone, up 4.3 points over five sessions.
Up 4.3 points over five sessions, from the Distribution zone.
Reading for Nov 13, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 12 | +1.1% | +5.2% | ||
| Accumulation | 113 | +1.9% | +7.3% | ||
| Neutral (current zone) | 440 | +0.7% | +3.6% | ||
| Distribution | 90 | +2.1% | +6.3% | ||
| Selling | 0 | Not available | |||
Average AHR share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +0.9% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
American Healthcare REIT trades 10.4% above Gekko Fair Value of $52.34, so the shares are overvalued on Gekko’s estimate.
Gekko’s own estimate of what American Healthcare REIT shares are worth, recalculated every trading day.
$52.34
Gekko Fair Value, Nov 14, 2026
10.4% Overvalued
At the end of Aug 2026 the price was 2.9% above the estimate.
No open-market insider purchases were filed for American Healthcare REIT, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for AHR in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in AHR were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
American Healthcare REIT has been buying back its own shares.
From company filings.
1of the funds Gekko tracks holds AHR.
American Healthcare REIT reports on Feb 25, 2027 (102 days away), and beat the EPS estimate in 1 of its last 8 reports.
Feb 25, 2027
102 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Aug 6, 2026 | $0.16 est $0.14 | $671.0M est $645.3M | +2.2% |
| May 7, 2026 | $0.13 est $0.16 | $650.8M est $667.6M | +3.4% |
| Feb 26, 2026 | $0.06 est $0.15 | $604.1M est $609.5M | −1.3% |
| Nov 6, 2025 | $0.33 est $0.42 | $572.9M est $615.4M | +4.9% |
| Aug 7, 2025 | $0.06 est $0.40 | $542.5M est $552.8M | +2.2% |
| May 8, 2025 | −$0.04 est $0.37 | $540.6M est $541.1M | +7.0% |
| Feb 27, 2025 | −$0.21 est $0.11 | $542.7M est $542.3M | +0.2% |
| Nov 12, 2024 | −$0.03 est −$0.01 | $523.8M est $474.3M | +1.2% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for American Healthcare REIT is $65.44, +13.3% from the last close, from 10 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 10 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Nov 13 | Bank of America Securities | $74 | +28.1% |
| Nov 11 | UBS | $71 | +22.9% |
| Nov 10 | Citi | $67 | +16.0% |
| Nov 9 | RBC Capital | $66 | +14.2% |
| Nov 6 | Scotiabank | $62 | +7.3% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
American Healthcare REIT’s market cap is $13.41B, with a P/E ratio of 119.7 and revenue of $2.67B over the last twelve months.
Coverage of American Healthcare REIT this week reads neutral: 5 positive, 7 neutral and 1 negative headlines.
American Healthcare REIT’s market cap is $13.41B at the Nov 13, 2026 close of $57.78, with 232.1M shares outstanding. The shares trade on a P/E ratio of 119.7.
The consensus analyst 12-month price target for American Healthcare REIT is $65.44, +13.3% from the last close. Of the 10 firms that rated the stock in the last 90 days, 10 rate it a buy, 0 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate American Healthcare REIT is overvalued: the Nov 13, 2026 close of $57.78 is 10.4% above Gekko Fair Value of $52.34. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
American Healthcare REIT is expected to report on Feb 25, 2027 (102 days away). Analysts expect earnings of $0.19 per share on revenue of $756.5M. American Healthcare REIT beat the earnings estimate in 1 of its last 8 reports, moving 2.8% on average across the report.
American Healthcare REIT’s 52-week high is $59.55 and its 52-week low is $44.81; it closed at $57.78 on Nov 13, 2026, +20.7% over the past year.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 4 items with data read as supportive (trend and earnings risk), 1 as mixed (gekkoindex) and 1 as a headwind (fair value). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,475 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.